SecBot SecBot
8-K ·Filed Aug 4, 2026

BRKR

BRUKER CORP
BULLISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001193125-26-331511
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The strong operational beat and margin expansion signal a turnaround in Bruker's core business, supported by robust bookings. The lowered revenue guidance is currency/tax-driven and not a demand issue. Traders should watch for continued margin expansion and organic growth in H2 2026, with the maintained EPS guidance implying stronger second-half performance.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$50.30
T+0 close · Aug 4, 2026 · via day close
Latest settled
+20.76%
T+60 · $60.74
Vs SPY
+20.97%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $50.30entry
  2. T+1 · 3mo ago +4.31%α +4.51% · $52.47
  3. T+5 · 3mo ago +13.36%α +13.46% · $57.02
  4. T+20 · 3mo ago +11.39%α +12.63% · $56.03
  5. T+60 · 19d ago +20.76%α +20.97% · $60.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Bruker reported Q2 2026 revenue of $838.5M (+5.2% YoY, +2.8% organic), beating consensus of $853.6M on the top line. Non-GAAP EPS of $0.49 was well above the $0.38 consensus estimate, driven by strong margin expansion (non-GAAP operating margin 14.1% vs 9.0% a year ago) and 10% organic bookings growth in the Scientific Instruments segment. The company slightly lowered its FY2026 revenue guidance range to $3.54-$3.57B (from $3.57-$3.60B) due to currency and tax, but maintained its non-GAAP EPS guidance of $2.10-$2.15. A $134.9M non-cash goodwill impairment charge drove a GAAP loss of $(0.41) per share, but the underlying operational beat and margin story are the key takeaways for the common stock.

Key Financial Metrics

EPS
$0.49
est $0.38 · +28.9%
Revenue
$838.5M
est $853.6M · -1.8% · +5.2% YoY
Rating
strong beat
Guidance
$3.54B-$3.57B
lowered
Free Cash Flow
-$106.2M
Gross Margin
49.6%

Key Facts

  • Q2 2026 revenue of $838.5M, +5.2% YoY, +2.8% organically
  • Non-GAAP EPS of $0.49 vs consensus $0.38, a 28.9% beat
  • Non-GAAP operating margin expanded to 14.1% from 9.0% YoY
  • BSI segment bookings up 10% organically YoY, book-to-bill >1.0x
  • FY2026 revenue guidance lowered to $3.54-$3.57B (from $3.57-$3.60B) on currency/tax; non-GAAP EPS guidance maintained at $2.10-$2.15
  • GAAP diluted loss per share of $(0.41) due to $134.9M goodwill impairment

Financial Impact

Non-GAAP EPS beat consensus by $0.11 (28.9%); revenue beat by $14.9M (1.8%)

revenuenon-GAAP EPSnon-GAAP operating marginbookings

Risk Factors

  • US academic demand remains soft, which could pressure future organic growth
  • Currency headwinds and tariff uncertainties continue to impact reported revenue
  • The $134.9M goodwill impairment raises questions about prior acquisition discipline

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
67% bullish (21 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-331511
Document: brkr-20260804.htm0001193125-26-331511
Document: 0001193125-26-331511-index-headers.html0001193125-26-331511
Document: 0001193125-26-331511-index.html0001193125-26-331511
Document: 0001193125-26-331511.txt0001193125-26-331511
8-K Data (Synthetic)0001193125-26-331511

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 4, 2026